PROTEASERESISTENTE LIPIDIERTE GLP-1-ANALOGA

Patent europeic · EP3307769 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3307769
Numer da la dumonda
EP16732248
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-06-2016
Publitgà
18-04-2018
Concedì
02-12-2020
La protecziun finescha il pli tard
08-06-2036
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 14/605 (2006.01)
A61K 38/26 (2006.01)
C12Q 1/37 (2006.01)
Prioritad
US 201562173631 P 10.06.2015
US 201662343390 P 31.05.2016
Dumonda PCT
PCT/EP2016/063206 09.06.2016
Publicaziun PCT
WO2016/198544 15.12.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  4. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  5. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  6. 13-10-2021

    Midada

    Published in Swissreg on 13.10.2021

  7. 02-12-2020

    Concedì

    Published in Swissreg on 02.12.2020

Partidas

Possessur

Medimmune Limited

MedImmune Limited

Milstein Building Granta Park, Cambridge Cambridgeshire CB21 6GH, GB

Inventur

BEDNAREK, Maria, A

Cambridge Cambridgeshire CB21 6GH, GB

REVELL, Jefferson, D

Cambridge Cambridgeshire CB21 6GH, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.